Background: Over the past decades, interest in establishing a National Rare Donor Program has increased significantly worldwide. The experience of developing countries, however, is still limited. Rare blood is defined as a blood group found in a 1000-5000 population and donor has an absence of a high-prevalence antigen, or the absence of multiple common antigens. Iranian national rare donor program was established in 2009. This paper reports the experiences and challenges of establishing a national rare donor program in Iran.
INTRODUCTION
For many years, one of the challenges in transfusion medicine was to ensure the availability of compatible units of rare blood for patients with either single or multiple blood group antibodies present 1 . These rare blood types may represent a significant impediment to both urgent and planned transfusion of red blood cells (RBCs) and also carry out important administrative and clinical challenges for the practitioner. Clinical guidelines address little about the management of patients with unique blood group. Patients who require blood from donors known as "rare blood donors" present unique challenges both at the preoperative health care delivery system at large and for the individual clinician who desires to maintain safe, efficient, and cost-effective care. It is most challenging to supply blood for a patient with an antibody to an antigen of high prevalence, with an occurrence rate of less than one in 1000 2 Often, there are other antibodies against common blood group antigens present with antibodies to high prevalence antigens, which provide a higher challenge 3 . Blood banks should answer the following questions: How frequently one is expected to encounter these patients? How frequently does a non-ABO hemolytic transfusion reaction occur if an alloimmunized patient is transfused on an emergent basis? What effect will be the advent of red cell molecular genotyping played in providing blood for patients with rare blood types? Are regional and national rare donor programs often able to cope with the majority of requests for rare blood RBC units? Unfortunately, few medical centers are aware of the existence of the program that organizes information about rare blood donors and seeks to assist providing rare blood. This article introduces activity of the IRL and challenges of establishing a national rare donor program in Iran with task to answer the above questions.
History of pioneering rare blood activities
The need for a rare donor registry was noted at an early stage of blood transfusion development. The UK blood group reference laboratory was established in 1946 for the national blood transfusion service 3 . By 1959, the AABB had improved the rare donor file, and the American Red Cross created the rare donor registry. Before merging their programs in 1998, the ARC and AABB • Participation in External Quality Assessment Scheme (EQAS) with unknown samples from international centers • Monthly production of RBC kits for determining antibody-screening strategy and detecting unexpected antibodies using frozen rare RBC aliquots.
• Training students and staff in specific serology.
Facts and figures
A total of 1300 rare donors were registered in this study. Fifty six individuals with rare Bombay blood group were identified in this survey. There were about 175 rare units in frozen state for transfusion. The most difficult types to find were Kpb negative, Rh null, K null, Jk(a-b-), S-s-U-. The average number of rare donor units used per year was close to 50
unites. Approximately 20 units of rare blood are delivered to the hospital via air or land transport annually. There are procedures in place to collect information when rare blood is forwarded and used. Special delivering form has been designed for this purpose.
Challenges and important step to ensure successful establishment of a National rare donor program
Packaging and reliable transportation
In order to transport the rare blood in liquid phase, a monitored temperature at 1-10 C should be maintained and standard commercially insulated and leak-proof boxes should be used. Several days may be required to keep a frozen supply of units of rare blood. As transport of such units over long distances presents a number of difficulties, special containers should be designed 1 . It is easier to ship frozen cells by glycerol and these can be stored in dry ice but deglycerolizing equipment should be available at the receiving facility. First of all, containers should be validated for their ability to maintain low-temperature storage for the required time period. Also, it is necessary to use data logger to record temperature information during transportation. Labeling of boxes should always be adequate. The labels should also have the full shipper address, full details of properly classified biological or infectious material, and the information on the container should indicate the contact party in case of delay in blood transport. For long-distance transport, the contract with specific airlines should be signed in order to transport the blood in a short period of time. The name and phone number of receiving center should be displayed on the outside of the container. Conformation of serological antibody testing and rare blood group identification are done at central IRL. It performs a crossmatch of any rare RBC units before shipping them in order to prevent misidentification or any discrepancies between IRL and medical center testing results. This might cause unnecessary delay or result in the loss of units. Therefore, the collection of a properly labeled pretransfusion blood specimen from the intended 
Standard Operating Procedures and use of a comprehensive Information Technology
All centers have specific standard operating procedures designed to support the activities related to the handling of Immunohematology procedures and rare blood units. Because of sudden and unexpected requests for rare blood types, all centers are equipped with computers. Some of the data items which need to be collected and placed in a computer database are as follows:  Donor personal information  Rare donor database of donors and their antigen type  Database for frozen unit inventory Requests must contain sufficient information for accurate recipient identification. Each center is required to develop and apply policies and procedures for accurate patient identification and specimen collection. Problems might exist in the preparation, storage and transportation of rare blood. Survey shows few known failures in the systems have resulted in: wasting rare blood, receiving the rare blood in an unsatisfactory condition, or a delay in the delivery of rare blood. Receiving centers are validated through acceptable performance of the procedure as well as proficiency of staff members.
Engineering and technical maintenance
Engineering staff are trained to follow proper storage requirements upon receipt of the blood from the remote blood centers during holidays and non-working hours. Temperature requirements during blood transport, monitoring of storage temperatures in refrigerators and freezers of blood component storage are available with continuous temperature monitoring devices that would be able to detect a temperature deviation before blood components might be affected. Daily checks of the temperature should be recorded by engineering staff in order to ensure proper operation of equipment and recorder.
Deviations from acceptable temperature ranges are annotated, dated and initialed on the temperature recording chart by the engineering staff who note the deviation, and appropriate correcting action is taken either in emergency or routine situations. The equipment should be so constructed as to sound an audible alarm when an abnormal situation is sensed.
Facility and freezing condition
Glycerol is most commonly used in RBC cryoprotectant and RBC units, in frozen state, are stored at 80°C (40% wt/vol glycerol, high-glycerol method). Frozen RBC expires after 10 years, but AABB standards permit storage of frozen units for 10 years 7 . Frozen units must be thawed, and prior to transfusion, the glycerol must be removed. The use of thawed RBCs is limited to 24-hour expiration when stored at 1°C to 6°C because of concerns related to potential bacterial contamination when a functionally open system is used to add and remove the glycerol. Thus, the critical care specialist should understand the transfusion planning purposes and notice that preservation of post-thaw rare blood unit is limited to hours, whereas frozen rare blood units may be preserved and stored for many years. The recently developed closed systems have an extended expiration date to 14 days for thawed, non-leukocyte-reduced, and deglycerolized RBCs when stored at 1°C to 6°C 8 . For extended storage of units in the case of antigen negative rare donor that is used in autologous or allogeneic transfusion, cellular components of RBCs are frozen, and for this reason, it is considered to provide appropriate equipment and various devices such as refrigerator and freezer. However, loss of absolute red cell mass which is resulted from red cell damage, will occur. High-glycerol freezing method is utilized, the 57.1% wt/vol high-glycerol, slow-freeze technique. During, thawing and deglycerolizing RBCs the freezing canister in which the RBC unit has been stored is placed in a 37 °C dry heaters, or, after overwrapping, is placed in a 37 °C water bath. When the red cells have been frozen in the primary blood container, then the container is thawed at 42 °C. Thawing is completed within 40 minutes 8, 9 . Employees with a college degree in one of the sciences such as laboratory science can be trained successfully to perform specific serologic tests. Staff should be promoted and provided opportunities to attend continuing education seminars on topics in serologic and related fields. In numerous states, continuing education is required for the renewal of licenses.
Financial and Administrative Support by Higher Management
Due to the cost of equipment and consumables used in rare blood banks, especially freezing and storage devices, budgeting in rare blood services need special attention and dedication by higher management and top managers of the bloodservice systems. So, the government is required to provide financial support to blood banks. According to the study of Geralyn et al., the cost of collecting, testing, storing and transporting blood to hospital transfusion service in the United States is approximately $925 to $1150 per RBC unit 8 . According to The American Rare Donor Program (ARDP), the cost of special antigen typing will rise to $500 -$1200 per each unit. Meanwhile, nearly $1940 to $2800 may be added to units imported to the United States 9 . Thus, the cost of a rare unit of blood in the United States ranges from approximately $1148 to $1373. Cost of preparing and handling a rare blood unit may differ between countries according to the policies of blood centers. To date, the rare blood services for patients are provided free of charge in Iran and all is paid by the government, including transportation charges.
DISCUSSION
During the past decades, interest in national rare donor program has increased in a significant manner worldwide. This is especially true in developed countries. In developing countries, however, the experience is not a lot. We report the results and challenges of the rare donor program, which was initiated in 2009. All activities used at IRL was based on those reported previously by different international organizations. In the current year, database consisted of 1300 personal information of rare donors and 308 RBC units in frozen state. As the proportion is similar to those reported by different countries, it is important to notice that this is the initial phase of our program, and we have evidence that this number will increase in the following years, as our collection program of donor and rare units improves.
According to the study of Woodfield, many areas of the world have problems in the storage, transportation and financing of rare blood Finally, in order to improve rare donor program, we have to overcome economic and other issues. So, the government should allocate sufficient budget for initial establishment and continuous improvement program of rare donor services of Iranian National Rare Donor Program. It is necessary to put a heavy emphasis on continuous education, training and improving knowledge of technologists with special reference to serology in various provincial blood donor centers. The importance level of services offered to patients with difficult samples by rare donor program should be promoted to prevent transfusion-related adverse effect. To overcome the lack of experience in using special immunohematology procedures as well as technical and human errors in reporting test results, effective contact and collaboration with
International Journal of Hematology Oncology and Stem Cell Research ijhoscr.tums.ac.ir international immunohematology reference laboratory for technical help and testing confirmation is required. Easy access to expensive internationally accepted anti-sera availability of automated machines, supplies and consumables for glycerolization and deglycerolization of rare RBCs should be provided. Moreover, there is a need for access to sufficient storage area and good environmental condition, sufficient number of -80°C standard freezers for longer blood storage, empty back up freezer, controlled access area temperature, controlled environment (-18 °C -22°C) by central heating and cooling system, central 24-hour temperature control, and alert system for any electrical failure. Finally, serious difficulties that occur in delivery of blood by Air and Land (bureaucratic procedures /ticket purchase / cancellation of flights/ flight delays), due to lack of experienced private companies, should also be considered.
